Direct Tie2 Agonists Stabilize Vasculature for the Treatment of Diabetic Macular Edema

PURPOSE: Diabetic macular edema (DME) is the leading cause of vision loss and blindness among working-age adults. Although current intravitreal anti-vascular endothelial growth factor (VEGF) therapies improve vision for many patients with DME, approximately half do not achieve the visual acuity requ...

Descripción completa

Detalles Bibliográficos
Autores principales: Agard, Nicholas J., Zhang, Gu, Ridgeway, John, Dicara, Danielle M., Chu, Phillip Y., Ohri, Rachana, Sanowar, Sarah, Vernes, Jean-Michel, Chi, Hannah, Zhang, Jiameng, Holz, Emily, Paluch, Maciej, He, Guannan, Benson, Yingjia, Zhang, Jianhuan, Chan, Pamela, Tang, Nga, Javale, Prachi, Wilson, Blair, Barrett, Kathy, Rowntree, Rebecca K., Hang, Julie, Meng, Y. Gloria, Hass, Phil, Fuh, Germaine, Piskol, Robert, Bantseev, Vladimir, Loyet, Kelly M., Tran, John C., Wu, Cong, Indjeian, Vahan B., Shivva, Vittal, Yan, Minhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2022
Materias:
Retina
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587485/
https://www.ncbi.nlm.nih.gov/pubmed/36255358
http://dx.doi.org/10.1167/tvst.11.10.27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587485/
https://www.ncbi.nlm.nih.gov/pubmed/36255358
http://dx.doi.org/10.1167/tvst.11.10.27

Ejemplares similares